^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AZD5069

    i
    Other names: AZD5069
    Associations
    News
    Trials
    Company:
    AstraZeneca
    Drug class:
    CXCR2 antagonist
    Related drugs:
    Associations
    News
    Trials